The ASCO Post 08.25.20 The Parker Institute for Cancer Immunotherapy Appoints John Connolly, PhD, as Chief Scientific Officer Read
Endpoints News 07.24.20 Turning cancer into a curable disease: Immunotherapy expert John Connolly picks up the reins as the new CSO of Sean Parker’s cancer institute Read
Multiple Myeloma Hub 07.09.20 How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease Read
Genetic Engineering and Biotechnology News 07.01.20 Leaps in Innovation in Cancer Immunology: An Expert Panel Discussion Read